Market Overview

Benzinga's Top Upgrades, Downgrades For January 3, 2020

Share:

Upgrades

  • For Alphabet Inc (NASDAQ: GOOGL), Canaccord Genuity upgraded the stock from Hold to Buy. In the third quarter, Alphabet showed an EPS of $10.12, compared to $13.06 from the year-ago quarter. The stock has a 52-week-high of $1368.68 and a 52-week-low of $1022.37. Alphabet's stock last closed at $1368.68 per share.
  • Oppenheimer changed the rating for Gilead Sciences Inc (NASDAQ: GILD) from Perform to Outperform. Gilead Sciences earned $1.75 in the third quarter, compared to $1.84 in the year-ago quarter. The stock has a 52-week-high of $70.50 and a 52-week-low of $60.89. Gilead Sciences's stock last closed at $65.23 per share.
  • For Canada Goose Holdings Inc (NYSE: GOOS), TD Securities upgraded the stock from Hold to Buy. In the second quarter, Canada Goose Holdings showed an EPS of $0.43, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $59.94 and a 52-week-low of $31.67. Canada Goose Holdings's stock last closed at $35.70 per share.
  • Stephens & Co. upgraded the stock for Credit Acceptance Corp (NASDAQ: CACC) from Underweight to Equal-Weight. In the third quarter, Credit Acceptance showed an EPS of $8.89, compared to $7.56 from the year-ago quarter. The stock has a 52-week-high of $509.99 and a 52-week-low of $373.06. Credit Acceptance's stock last closed at $442.77 per share.
  • Stephens & Co. upgraded the stock for Q2 Holdings Inc (NYSE: QTWO) from Equal-Weight to Overweight. In the third quarter, Q2 Holdings showed an EPS of $0.05, compared to $0.09 from the year-ago quarter. The stock has a 52-week-high of $93.63 and a 52-week-low of $46.12. Q2 Holdings's stock last closed at $82.79 per share.
  • Stephens & Co. upgraded the stock for Synchrony Financial (NYSE: SYF) from Underweight to Equal-Weight. Synchrony Finl earned $1.22 in the third quarter, compared to $0.91 in the year-ago quarter. The stock has a 52-week-high of $38.18 and a 52-week-low of $23.12. Synchrony Finl's stock last closed at $36.20 per share.
  • UBS changed the rating for Illumina Inc (NASDAQ: ILMN) from Neutral to Buy. Illumina earned $1.93 in the third quarter, compared to $1.52 in the year-ago quarter. The stock has a 52-week-high of $380.76 and a 52-week-low of $263.30. Illumina's stock last closed at $327.00 per share.
  • Guggenheim changed the rating for Incyte Corp (NASDAQ: INCY) from Neutral to Buy. Incyte earned $0.82 in the third quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $96.79 and a 52-week-low of $62.03. Incyte's stock last closed at $85.97 per share.
  • For Waters Corp (NYSE: WAT), Bank of America upgraded the stock from Underperform to Neutral. Waters earned $2.13 in the third quarter, compared to $1.92 in the year-ago quarter. The stock has a 52-week-high of $255.21 and a 52-week-low of $174.95. Waters's stock last closed at $235.07 per share.
  • For Cintas Corp (NASDAQ: CTAS), Bank of America upgraded the stock from Neutral to Buy. In the second quarter, Cintas showed an EPS of $2.27, compared to $1.76 from the year-ago quarter. The stock has a 52-week-high of $277.85 and a 52-week-low of $164.50. Cintas's stock last closed at $270.79 per share.
  • For Karyopharm Therapeutics Inc (NASDAQ: KPTI), Bank of America upgraded the stock from Underperform to Neutral. For the third quarter, Karyopharm Therapeutics had an EPS of ($0.67), compared to year-ago quarter EPS of ($0.79). The stock has a 52-week-high of $20.00 and a 52-week-low of $3.92. Karyopharm Therapeutics's stock last closed at $18.72 per share.
  • Bank of America upgraded the stock for Teva Pharmaceutical Industries Ltd (NYSE: TEVA) from Underperform to Buy. For the third quarter, Teva Pharmaceutical Indus had an EPS of $0.58, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of $20.21 and a 52-week-low of $6.07. Teva Pharmaceutical Indus's stock last closed at $9.56 per share.
  • Credit Suisse upgraded the stock for Emerson Electric Co (NYSE: EMR) from Neutral to Outperform. In the fourth quarter, Emerson Electric showed an EPS of $1.07, compared to $0.89 from the year-ago quarter. The stock has a 52-week-high of $77.51 and a 52-week-low of $55.98. Emerson Electric's stock last closed at $77.48 per share.
  • For Honeywell International Inc (NYSE: HON), Credit Suisse upgraded the stock from Neutral to Outperform. For the third quarter, Honeywell International had an EPS of $2.08, compared to year-ago quarter EPS of $2.03. The stock has a 52-week-high of $183.12 and a 52-week-low of $129.07. Honeywell International's stock last closed at $180.79 per share.
  • Raymond James changed the rating for Cigna Corp (NYSE: CI) from Market Perform to Outperform. For the third quarter, Cigna had an EPS of $4.54, compared to year-ago quarter EPS of $3.84. The stock has a 52-week-high of $207.28 and a 52-week-low of $141.95. Cigna's stock last closed at $204.93 per share.
  • Goldman Sachs upgraded the stock for Canadian Solar Inc (NASDAQ: CSIQ) from Neutral to Buy. In the third quarter, Canadian Solar showed an EPS of $0.66, compared to $1.09 from the year-ago quarter. The stock has a 52-week-high of $25.89 and a 52-week-low of $14.00. Canadian Solar's stock last closed at $22.52 per share.
  • Evercore ISI Group upgraded the stock for Anthem Inc (NYSE: ANTM) from In-Line to Outperform. Anthem earned $4.87 in the third quarter, compared to $3.81 in the year-ago quarter. The stock has a 52-week-high of $317.99 and a 52-week-low of $227.16. Anthem's stock last closed at $300.82 per share.
  • Longbow Research changed the rating for Belden Inc (NYSE: BDC) from Neutral to Buy. Belden earned $1.18 in the third quarter, compared to $1.72 in the year-ago quarter. The stock has a 52-week-high of $64.33 and a 52-week-low of $40.67. Belden's stock last closed at $55.25 per share.

 

Downgrades

  • Stephens & Co. downgraded the stock for ACI Worldwide Inc (NASDAQ: ACIW) from Overweight to Equal-Weight. For the third quarter, ACI Worldwide had an EPS of $0.27, compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $38.44 and a 52-week-low of $25.12. ACI Worldwide's stock last closed at $38.20 per share.
  • Stephens & Co. downgraded the stock for Genesee & Wyoming Inc (NYSE: GWR) from Overweight to Equal-Weight. In the third quarter, Genesee & Wyoming showed an EPS of $1.16, compared to $1.23 from the year-ago quarter.
  • UBS downgraded the stock for USA Compression Partners LP (NYSE: USAC) from Buy to Neutral. USA Compression Partners earned $0.02 in the third quarter, compared to ($0.07) in the year-ago quarter. The stock has a 52-week-high of $19.00 and a 52-week-low of $12.75. USA Compression Partners's stock last closed at $17.95 per share.
  • Guggenheim downgraded the stock for Puma Biotechnology Inc (NASDAQ: PBYI) from Buy to Neutral. In the third quarter, Puma Biotechnology showed an EPS of ($0.44), compared to ($0.37) from the year-ago quarter. The stock has a 52-week-high of $43.90 and a 52-week-low of $6.26. Puma Biotechnology's stock last closed at $8.43 per share.
  • Jefferies downgraded the stock for Apple Inc (NASDAQ: AAPL) from Buy to Hold. Apple earned $3.03 in the fourth quarter, compared to $2.91 in the year-ago quarter. The stock has a 52-week-high of $300.60 and a 52-week-low of $142.00. Apple's stock last closed at $300.35 per share.
  • Stephens & Co. downgraded the stock for Rent-A-Center Inc (NASDAQ: RCII) from Equal-Weight to Underweight. In the third quarter, Rent-A-Center showed an EPS of $0.47, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $28.99 and a 52-week-low of $15.88. Rent-A-Center's stock last closed at $28.47 per share.
  • Loop Capital downgraded the stock for Apple Inc (NASDAQ: AAPL) from Buy to Hold. Apple earned $3.03 in the fourth quarter, compared to $2.91 in the year-ago quarter. The stock has a 52-week-high of $300.60 and a 52-week-low of $142.00. Apple's stock last closed at $300.35 per share.
  • For Lumber Liquidators Holdings Inc (NYSE: LL), Loop Capital downgraded the stock from Buy to Hold. For the third quarter, Lumber Liquidators Hldgs had an EPS of $0.08, compared to year-ago quarter EPS of $0.27. The stock has a 52-week-high of $14.44 and a 52-week-low of $6.59. Lumber Liquidators Hldgs's stock last closed at $9.54 per share.
  • Bank of America changed the rating for Robert Half International Inc (NYSE: RHI) from Buy to Neutral. For the third quarter, Robert Half International had an EPS of $1.01, compared to year-ago quarter EPS of $0.95. The stock has a 52-week-high of $69.08 and a 52-week-low of $51.90. Robert Half International's stock last closed at $63.73 per share.
  • Bank of America changed the rating for Quest Diagnostics Inc (NYSE: DGX) from Neutral to Underperform. Quest Diagnostics earned $1.76 in the third quarter, compared to $1.68 in the year-ago quarter. The stock has a 52-week-high of $108.95 and a 52-week-low of $79.93. Quest Diagnostics's stock last closed at $105.73 per share.
  • For Mettler-Toledo International Inc (NYSE: MTD), Bank of America downgraded the stock from Buy to Neutral. For the third quarter, Mettler-Toledo Intl had an EPS of $5.77, compared to year-ago quarter EPS of $5.12. The stock has a 52-week-high of $873.51 and a 52-week-low of $500.74. Mettler-Toledo Intl's stock last closed at $805.14 per share.
  • Bank of America changed the rating for NewLink Genetics Corp (NASDAQ: NLNK) from Neutral to Underperform. For the third quarter, NewLink Genetics had an EPS of ($0.39), compared to year-ago quarter EPS of ($0.20). The stock has a 52-week-high of $3.60 and a 52-week-low of $1.13. NewLink Genetics's stock last closed at $2.26 per share.
  • Bank of America changed the rating for Laboratory Corp of America Holdings (NYSE: LH) from Neutral to Underperform. For the third quarter, Laboratory Corp had an EPS of $2.90, compared to year-ago quarter EPS of $2.74. The stock has a 52-week-high of $178.44 and a 52-week-low of $122.27. Laboratory Corp's stock last closed at $167.49 per share.
  • Bank of America downgraded the stock for CBRE Group Inc (NYSE: CBRE) from Buy to Neutral. In the third quarter, CBRE Group showed an EPS of $0.79, compared to $0.79 from the year-ago quarter. The stock has a 52-week-high of $61.90 and a 52-week-low of $37.85. CBRE Group's stock last closed at $61.47 per share.
  • Bank of America changed the rating for Industrial Logistics Properties Trust (NASDAQ: ILPT) from Neutral to Underperform. Industrial Logistics earned $0.44 in the third quarter, compared to $0.39 in the year-ago quarter. The stock has a 52-week-high of $23.16 and a 52-week-low of $18.03. Industrial Logistics's stock last closed at $22.12 per share.
  • Bank of America downgraded the stock for Jones Lang LaSalle Inc (NYSE: JLL) from Buy to Underperform. For the third quarter, Jones Lang LaSalle had an EPS of $3.52, compared to year-ago quarter EPS of $3.02. The stock has a 52-week-high of $175.99 and a 52-week-low of $119.79. Jones Lang LaSalle's stock last closed at $175.29 per share.
  • Bank of America downgraded the stock for AbbVie Inc (NYSE: ABBV) from Buy to Neutral. For the third quarter, AbbVie had an EPS of $2.33, compared to year-ago quarter EPS of $2.14. The stock has a 52-week-high of $92.30 and a 52-week-low of $62.66. AbbVie's stock last closed at $89.56 per share.
  • Mizuho downgraded the stock for American Electric Power Co Inc (NYSE: AEP) from Buy to Neutral. In the third quarter, American Electric Power showed an EPS of $1.46, compared to $1.26 from the year-ago quarter. The stock has a 52-week-high of $96.22 and a 52-week-low of $72.25. American Electric Power's stock last closed at $93.46 per share.
  • Berenberg changed the rating for Albemarle Corp (NYSE: ALB) from Buy to Hold. In the third quarter, Albemarle showed an EPS of $1.53, compared to $1.31 from the year-ago quarter. The stock has a 52-week-high of $93.14 and a 52-week-low of $58.63. Albemarle's stock last closed at $72.59 per share.
  • Macquarie downgraded the stock for Apple Inc (NASDAQ: AAPL) from Outperform to Neutral. For the fourth quarter, Apple had an EPS of $3.03, compared to year-ago quarter EPS of $2.91. The stock has a 52-week-high of $300.60 and a 52-week-low of $142.00. Apple's stock last closed at $300.35 per share.
  • For Equity Bancshares Inc (NASDAQ: EQBK), Keefe Bruyette & Woods downgraded the stock from Outperform to Market Perform. In the third quarter, Equity Bancshares showed an EPS of $0.66, compared to $0.68 from the year-ago quarter. The stock has a 52-week-high of $35.96 and a 52-week-low of $22.75. Equity Bancshares's stock last closed at $30.13 per share.
  • Evercore ISI Group downgraded the stock for Henry Schein Inc (NASDAQ: HSIC) from In-Line to Underperform. Henry Schein earned $0.90 in the third quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of $72.81 and a 52-week-low of $56.58. Henry Schein's stock last closed at $67.12 per share.

 

Initiations

  • Needham initiated coverage on Waters Corp (NYSE: WAT) with a Hold rating. The price target for Waters is set at $177.00. In the third quarter, Waters showed an EPS of $2.13, compared to $1.92 from the year-ago quarter. The stock has a 52-week-high of $255.21 and a 52-week-low of $174.95. Waters's stock last closed at $235.07 per share.
  • Deutsche Bank initiated coverage on Universal Health Services Inc (NYSE: UHS) with a Buy rating. The price target for Universal Health Services is set at $140.00. Universal Health Services earned $1.99 in the third quarter, compared to $2.23 in the year-ago quarter. The stock has a 52-week-high of $157.79 and a 52-week-low of $114.85. Universal Health Services's stock last closed at $142.33 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Vulcan Materials Co (NYSE: VMC). The price target is set at $116.00 for Vulcan Materials. For the third quarter, Vulcan Materials had an EPS of $1.68, compared to year-ago quarter EPS of $1.40. The stock has a 52-week-high of $152.49 and a 52-week-low of $95.31. Vulcan Materials's stock last closed at $142.67 per share.
  • Deutsche Bank initiated coverage on Zimmer Biomet Holdings Inc (NYSE: ZBH) with a Hold rating. The price target for Zimmer Biomet Holdings is set at $108.00. In the third quarter, Zimmer Biomet Holdings showed an EPS of $1.77, compared to $1.63 from the year-ago quarter. The stock has a 52-week-high of $151.67 and a 52-week-low of $98.60. Zimmer Biomet Holdings's stock last closed at $149.16 per share.
  • Needham initiated coverage on Thermo Fisher Scientific Inc (NYSE: TMO) with a Strong Buy rating. The price target for Thermo Fisher Scientific is set at $271.00. In the third quarter, Thermo Fisher Scientific showed an EPS of $2.94, compared to $2.62 from the year-ago quarter. The stock has a 52-week-high of $330.14 and a 52-week-low of $210.07. Thermo Fisher Scientific's stock last closed at $326.28 per share.
  • William Blair initiated coverage on OptimizeRx Corp (NASDAQ: OPRX) with an Outperform rating. In the third quarter, OptimizeRx showed an EPS of ($0.05), compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of $17.24 and a 52-week-low of $8.63. OptimizeRx's stock last closed at $9.97 per share.
  • Needham initiated coverage on PerkinElmer Inc (NYSE: PKI) with a Hold rating. The price target for PerkinElmer is set at $79.00. In the third quarter, PerkinElmer showed an EPS of $1.06, compared to $0.90 from the year-ago quarter. The stock has a 52-week-high of $103.00 and a 52-week-low of $72.16. PerkinElmer's stock last closed at $98.89 per share.
  • Deutsche Bank initiated coverage on Stryker Corp (NYSE: SYK) with a Buy rating. The price target for Stryker is set at $179.00. For the third quarter, Stryker had an EPS of $1.91, compared to year-ago quarter EPS of $1.69. The stock has a 52-week-high of $223.45 and a 52-week-low of $151.63. Stryker's stock last closed at $210.50 per share.
  • With a rating of Hold, Deutsche Bank initiated coverage on Tenet Healthcare Corp (NYSE: THC). The price target is set at $20.00 for Tenet Healthcare. Tenet Healthcare earned $0.58 in the third quarter, compared to $0.29 in the year-ago quarter. The stock has a 52-week-high of $39.37 and a 52-week-low of $16.77. Tenet Healthcare's stock last closed at $38.33 per share.
  • With a rating of Buy, Needham initiated coverage on NeoGenomics Inc (NASDAQ: NEO). The price target is set at $14.00 for NeoGenomics. In the third quarter, NeoGenomics showed an EPS of $0.07, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $30.00 and a 52-week-low of $12.04. NeoGenomics's stock last closed at $29.05 per share.
  • Needham initiated coverage on Myriad Genetics Inc (NASDAQ: MYGN) with a Strong Buy rating. The price target for Myriad Genetics is set at $36.00. In the first quarter, Myriad Genetics showed an EPS of $0.08, compared to $0.43 from the year-ago quarter. The stock has a 52-week-high of $48.40 and a 52-week-low of $20.10. Myriad Genetics's stock last closed at $27.35 per share.
  • With a rating of Buy, SunTrust Robinson Humphrey initiated coverage on Integra Lifesciences Holdings Corp (NASDAQ: IART). The price target is set at $56.00 for Integra Lifesciences. In the third quarter, Integra Lifesciences showed an EPS of $0.68, compared to $0.59 from the year-ago quarter. The stock has a 52-week-high of $65.09 and a 52-week-low of $42.14. Integra Lifesciences's stock last closed at $57.87 per share.
  • Deutsche Bank initiated coverage on Mednax Inc (NYSE: MD) with a Hold rating. The price target for Mednax is set at $34.00. In the third quarter, Mednax showed an EPS of $0.91, compared to $0.94 from the year-ago quarter. The stock has a 52-week-high of $38.88 and a 52-week-low of $19.93. Mednax's stock last closed at $27.49 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Medtronic PLC (NYSE: MDT). The price target is set at $99.00 for Medtronic. For the second quarter, Medtronic had an EPS of $1.31, compared to year-ago quarter EPS of $1.22. The stock has a 52-week-high of $115.94 and a 52-week-low of $81.66. Medtronic's stock last closed at $114.56 per share.
  • With a rating of Buy, Deutsche Bank initiated coverage on Martin Marietta Materials Inc (NYSE: MLM). The price target is set at $198.00 for Martin Marietta Materials. In the third quarter, Martin Marietta Materials showed an EPS of $3.96, compared to $2.85 from the year-ago quarter. The stock has a 52-week-high of $281.82 and a 52-week-low of $167.62. Martin Marietta Materials's stock last closed at $276.57 per share.
  • Deutsche Bank initiated coverage on HCA Healthcare Inc (NYSE: HCA) with a Buy rating. The price target for HCA Healthcare is set at $140.00. HCA Healthcare earned $2.23 in the third quarter, compared to $2.16 in the year-ago quarter. The stock has a 52-week-high of $150.17 and a 52-week-low of $110.31. HCA Healthcare's stock last closed at $147.47 per share.
  • Needham initiated coverage on Danaher Corp (NYSE: DHR) with a Buy rating. The price target for Danaher is set at $114.00. Danaher earned $1.16 in the third quarter, compared to $1.10 in the year-ago quarter. The stock has a 52-week-high of $155.24 and a 52-week-low of $96.44. Danaher's stock last closed at $155.19 per share.
  • With a rating of Neutral, Goldman Sachs initiated coverage on Cision Ltd (NYSE: CISN). The price target is set at $12.00 for Cision. For the third quarter, Cision had an EPS of $0.21, compared to year-ago quarter EPS of $0.20. The stock has a 52-week-high of $14.55 and a 52-week-low of $6.02. Cision's stock last closed at $9.96 per share.
  • Deutsche Bank initiated coverage on DaVita Inc (NYSE: DVA) with a Buy rating. The price target for DaVita is set at $60.00. In the third quarter, DaVita showed an EPS of $1.53, compared to $0.56 from the year-ago quarter. The stock has a 52-week-high of $75.40 and a 52-week-low of $43.40. DaVita's stock last closed at $75.24 per share.
  • With a rating of Hold, Deutsche Bank initiated coverage on Edwards Lifesciences Corp (NYSE: EW). The price target is set at $164.00 for Edwards Lifesciences. Edwards Lifesciences earned $1.41 in the third quarter, compared to $1.07 in the year-ago quarter. The stock has a 52-week-high of $247.64 and a 52-week-low of $140.86. Edwards Lifesciences's stock last closed at $232.49 per share.
  • With a rating of Buy, UBS initiated coverage on Cheniere Energy Inc (AMEX: LNG). The price target is set at $72.00 for Cheniere Energy. For the third quarter, Cheniere Energy had an EPS of ($1.14), compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $70.60 and a 52-week-low of $57.36. Cheniere Energy's stock last closed at $62.23 per share.
  • Needham initiated coverage on Ceridian HCM Holding Inc (NYSE: CDAY) with a Buy rating. The price target for Ceridian HCM Holding is set at $40.00. In the third quarter, Ceridian HCM Holding showed an EPS of $0.11, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $70.04 and a 52-week-low of $33.16. Ceridian HCM Holding's stock last closed at $70.00 per share.
  • Needham initiated coverage on Bruker Corp (NASDAQ: BRKR) with a Strong Buy rating. The price target for Bruker is set at $39.00. Bruker earned $0.43 in the third quarter, compared to $0.37 in the year-ago quarter. The stock has a 52-week-high of $52.23 and a 52-week-low of $28.02. Bruker's stock last closed at $51.36 per share.
  • With a rating of Neutral, UBS initiated coverage on Cheniere Energy Partners LP (AMEX: CQP). The price target is set at $38.00 for Cheniere Energy Partners. In the third quarter, Cheniere Energy Partners showed an EPS of $0.19, compared to $0.60 from the year-ago quarter. The stock has a 52-week-high of $49.30 and a 52-week-low of $35.25. Cheniere Energy Partners's stock last closed at $39.40 per share.
  • Needham initiated coverage on Agilent Technologies Inc (NYSE: A) with a Buy rating. The price target for Agilent Technologies is set at $77.00. Agilent Technologies earned $0.89 in the fourth quarter, compared to $0.81 in the year-ago quarter. The stock has a 52-week-high of $86.35 and a 52-week-low of $62.00. Agilent Technologies's stock last closed at $85.92 per share.
  • With a rating of Hold, Deutsche Bank initiated coverage on American Renal Associates Holdings Inc (NYSE: ARA). The price target is set at $12.00 for American Renal Associates. American Renal Associates earned $0.33 in the third quarter, compared to $0.19 in the year-ago quarter. The stock has a 52-week-high of $14.11 and a 52-week-low of $5.48. American Renal Associates's stock last closed at $9.76 per share.
  • Deutsche Bank initiated coverage on Acadia Healthcare Co Inc (NASDAQ: ACHC) with a Hold rating. The price target for Acadia Healthcare Co is set at $27.00. Acadia Healthcare Co earned $0.52 in the third quarter, compared to $0.53 in the year-ago quarter. The stock has a 52-week-high of $35.40 and a 52-week-low of $25.13. Acadia Healthcare Co's stock last closed at $33.15 per share.
 

Related Articles (LNG)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
NTNXNeedhamMaintains43.0
HUTHC Wainwright & Co.Initiates Coverage On14.0
IMABPiper SandlerInitiates Coverage On75.0
MMSINeedhamMaintains68.0
CHRSHC Wainwright & Co.Maintains29.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com